(Q50883844)

24 March 2018

title

Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. (English)

1 reference

24 March 2018

0 references

1 reference

Mingyao Meng

1

1 reference

24 March 2018

Wenju Wang

2

1 reference

24 March 2018

Jun Yan

3

1 reference

24 March 2018

Jing Tan

4

1 reference

24 March 2018

Liwei Liao

5

1 reference

24 March 2018

Jianlin Shi

6

1 reference

24 March 2018

Chuanyu Wei

7

1 reference

24 March 2018

Yanhua Xie

8

1 reference

24 March 2018

Xingfang Jin

9

1 reference

24 March 2018

Li Yang

10

1 reference

24 March 2018

Qing Jin

11

1 reference

24 March 2018

Huirong Zhu

12

1 reference

24 March 2018

Weiwei Tan

13

1 reference

24 March 2018

Fang Yang

14

1 reference

24 March 2018

Zongliu Hou

15

1 reference

24 March 2018

publication date

3 February 2016

1 reference

24 March 2018

published in

Tumor Biology

1 reference

24 March 2018

volume

37

1 reference

24 March 2018

issue

8

1 reference

24 March 2018

page(s)

10317-10327

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-016-4825-4

exact match

0 references

cites work

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Microenvironmental regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

T cell exclusion, immune privilege, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Microenvironmental regulation of tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Identification and characterization of a fibroblast marker: FSP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

On cross-priming of MHC class I-specific CTL: rule or exception?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4825-4

Early role of Fsp1 in epithelial-mesenchymal transformation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26842926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26842926

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-016-4825-4

1 reference

24 March 2018

PubMed ID

26842926

1 reference

24 March 2018